Ascertaining the Utility of the Glycemia Risk Index for Glucose Outcomes With Hybrid Closed-Loop Therapy in Adolescents and Adults With Type 1 Diabetes.

Thivolet, Charles; Lebbar, Maha; Perge, Kevin; Nicolino, Marc; Villar-Fimbel, Sylvie

Thivolet, Charles; Lebbar, Maha; Perge, Kevin; Nicolino, Marc; Villar-Fimbel, Sylvie.

Afiliação

Thivolet C; Center for Diabetes DIAB-eCARE, Hospices Civils de Lyon, Lyon, France.
Lebbar M; Center for Diabetes DIAB-eCARE, Hospices Civils de Lyon, Lyon, France.
Perge K; Department of Paediatric Endocrinology and Diabetes, Hospices Civils de Lyon, Bron, France.
Nicolino M; Center for Diabetes DIAB-eCARE, Hospices Civils de Lyon, Lyon, France.
Villar-Fimbel S; Department of Paediatric Endocrinology and Diabetes, Hospices Civils de Lyon, Bron, France.

J Diabetes Sci Technol ; : 19322968241258742, 2024 Jul 30.

Article em En | MEDLINE | ID: mdl-39076117

Palavras-chave

automated insulin delivery; closed-loop system; diabetes; glycemia risk index; hyperglycaemia; hypoglycaemia; real-world evidence; time in range

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article